Location:

Kowloon Bay, Hong Kong

Year of Completion:

2021

Project Description:

Commissioned by Hybribio—China’s leading provider of nucleic acid molecular diagnostic solutions—the project reflects the brand’s commitment to innovation, precision, and scientific excellence. Listed on the Growth Enterprise Market of the Shenzhen Stock Exchange since 2017, Hybribio operates across a fully integrated chain encompassing research and development, production, and sales.

Share
Go BackGo Back